37. Which assessment finding in a patient who has received omalizumab (Xolair) is most important to report immediately to the health care provider? a. Pain at injection site c. Peak flow reading 75%... of normal b. Flushing and dizziness d. Respiratory rate 24 breaths/minute ANS: B Flushing and dizziness may indicate that the patient is experiencing an anaphylactic reaction, and immediate intervention is needed. The other information should also be reported, but do not indicate possibly lifethreatening complications of omalizumab therapy. [Show More]
Last updated: 1 year ago
Preview 1 out of 25 pages
Connected school, study & course
About the document
Uploaded On
Jun 12, 2021
Number of pages
25
Written in
This document has been written for:
Uploaded
Jun 12, 2021
Downloads
0
Views
47
In Browsegrades, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.
We're available through e-mail, Twitter, Facebook, and live chat.
FAQ
Questions? Leave a message!
Copyright © Browsegrades · High quality services·